Inspections, Compliance, Enforcement, and Criminal Investigations
OST Medical, Inc. Response Letter
OST Medical
March 9, 2005
FDA, DISTRICT OFFICE
ONE MONTVALE AVE. 4th Flr
STONEHAM, MA 02180
Attention: Karen Archdeacon
RE: Response to 7-19-04 Warning Letter, NWE-31-04W
Dear Ms. Archdeacon,
OST Medical has received a letter from the Food and Drug Administration dated September 8, 2004. With respect to the subject of premarket notification (510(k) no. K011587), this letter states that, following a review of additional information provided by OST Medical, Inc., the FDA Center for Devices and Radiological Health (CDRH) has concluded that the documentation is adequate, and therefore, no new 510(k) is required at this time.
Sincerely,
/s/
Peter Sacchetti
President
OST MEDICAL, INCORPORATED 11 KNIGHT ST. BLDG F23 WARWICK RI 02886
T 401-737-3774 F 401-737-4519 sales@ostmedical .com







